Display options
Cite
Dallery J, Raiff BR, Grabinski MJ, et al. Technology-Based Contingency Management in the Treatment of Substance-Use Disorders. Perspect Behav Sci. 2019;42(3):445-464doi: 10.1007/s40614-019-00214-1.
Dallery, J., Raiff, B. R., Grabinski, M. J., & Marsch, L. A. (2019). Technology-Based Contingency Management in the Treatment of Substance-Use Disorders. Perspectives on behavior science, 42(3), 445-464. https://doi.org/10.1007/s40614-019-00214-1
Dallery, Jesse, et al. "Technology-Based Contingency Management in the Treatment of Substance-Use Disorders." Perspectives on behavior science vol. 42,3 (2019): 445-464. doi: https://doi.org/10.1007/s40614-019-00214-1
Dallery J, Raiff BR, Grabinski MJ, Marsch LA. Technology-Based Contingency Management in the Treatment of Substance-Use Disorders. Perspect Behav Sci. 2019 Jul 09;42(3):445-464. doi: 10.1007/s40614-019-00214-1. eCollection 2019 Sep. PMID: 31976444; PMCID: PMC6768925.
Copy Download .nbib Format: NLM
Share it on

Perspect Behav Sci. 2019 Jul 09;42(3):445-464. doi: 10.1007/s40614-019-00214-1. eCollection 2019 Sep.

Technology-Based Contingency Management in the Treatment of Substance-Use Disorders.

Perspectives on behavior science

Jesse Dallery, Bethany R Raiff, Michael J Grabinski, Lisa A Marsch

Affiliations

  1. 1Department of Psychology, University of Florida, PO Box 112250, Gainesville, FL 32611 USA.
  2. 2Rowan University, Glassboro, NJ USA.
  3. Red5hift, LLC, Hanover, NH USA.
  4. 4The Geisel School of Medicine, Dartmouth College, Hanover, NH USA.

PMID: 31976444 PMCID: PMC6768925 DOI: 10.1007/s40614-019-00214-1

Abstract

Contingency management is one of the most efficacious interventions to promote drug abstinence. Contingency management has traditionally been delivered in person so that clinicians could confirm drug abstinence and provide access to additional therapeutic services. Now, new technologies not only permit remote confirmation of abstinence, but also remote delivery of incentives. We discuss several technology-based tools to assess substance use, and new ways to deliver contingency management to promote tobacco, alcohol, and cannabis abstinence. These new tools have the potential to dramatically increase access while maintaining high levels of treatment fidelity. Technology-based methods also allow arranging group contingencies that harness online communities, and they permit targeting multiple health-risk behaviors with a combination of sensor-based technologies. Overall, there are unprecedented opportunities to link technology with contingency management to promote drug abstinence.

© Association for Behavior Analysis International 2019.

Keywords: Contingency management; Incentives; Substance-use disorders; Technology

References

  1. J Appl Behav Anal. 2013 Dec;46(4):750-64 - PubMed
  2. JMIR Mhealth Uhealth. 2018 Dec 18;6(12):e11708 - PubMed
  3. J Public Health (Oxf). 2012 Mar;34 Suppl 1:i3-10 - PubMed
  4. Prev Med. 2008 Mar;46(3):181-8 - PubMed
  5. Addict Behav. 1977;2(1):9-14 - PubMed
  6. Drug Alcohol Depend. 2014 Sep 1;142:301-6 - PubMed
  7. Addiction. 2010 Sep;105(9):1507-9 - PubMed
  8. Addict Behav. 2018 Apr;79:86-92 - PubMed
  9. Addiction. 2009 Sep;104(9):1530-8 - PubMed
  10. N Engl J Med. 2007 Sep 20;357(12):1221-8 - PubMed
  11. Drug Alcohol Depend. 2016 Apr 1;161:119-26 - PubMed
  12. J Appl Behav Anal. 2005 Fall;38(3):349-57 - PubMed
  13. J Soc Distress Homeless. 2017;26(1):73-77 - PubMed
  14. Drug Alcohol Depend. 2011 Oct 1;118(1):23-30 - PubMed
  15. Drug Alcohol Depend. 2009 Nov 1;105(1-2):56-62 - PubMed
  16. Rev Mex Anal Conducta. 2014 Sep;40(2):106-126 - PubMed
  17. Clin Pharmacol Ther. 2008 Apr;83(4):644-7 - PubMed
  18. Exp Clin Psychopharmacol. 2013 Jun;21(3):204-13 - PubMed
  19. Addict Behav. 2018 Aug;83:56-63 - PubMed
  20. Behav Anal. 2014 Aug 23;38(1):19-49 - PubMed
  21. Annu Rev Psychol. 2004;55:431-61 - PubMed
  22. Drug Alcohol Depend. 2006 Oct 15;85(1):19-27 - PubMed
  23. Behav Res Ther. 1980;18(1):45-50 - PubMed
  24. J Subst Abuse Treat. 2014 Nov-Dec;47(5):329-38 - PubMed
  25. J Appl Behav Anal. 2008 Winter;41(4):579-95 - PubMed
  26. J Appl Behav Anal. 1986 Summer;19(2):197-202 - PubMed
  27. Am Psychol. 2015 Feb-Mar;70(2):75-90 - PubMed
  28. Drug Alcohol Depend. 2011 Nov 1;118(2-3):391-9 - PubMed
  29. BMJ. 2012 Jan 30;344:e522 - PubMed
  30. J Appl Behav Anal. 1982 Winter;15(4):533-44 - PubMed
  31. N Engl J Med. 2008 May 22;358(21):2249-58 - PubMed
  32. J Med Internet Res. 2018 Jun 19;20(6):e10528 - PubMed
  33. Addiction. 2006 Nov;101(11):1546-60 - PubMed
  34. Depress Anxiety. 2018 Nov;35(11):1056-1072 - PubMed
  35. J Consult Clin Psychol. 1986 Aug;54(4):447-53 - PubMed
  36. Addiction. 2005 Feb;100(2):159-67 - PubMed
  37. Behav Res Ther. 1981;19(2):117-23 - PubMed
  38. Front Psychiatry. 2018 Mar 01;9:51 - PubMed
  39. Addiction. 2017 Jun;112(6):1025-1035 - PubMed
  40. Health Psychol Rev. 2015;9(4):434-51 - PubMed
  41. Am J Psychiatry. 1993 May;150(5):763-9 - PubMed
  42. J Appl Behav Anal. 1968 Spring;1(1):91-7 - PubMed
  43. Health Educ Res. 2010 Feb;25(1):74-82 - PubMed
  44. Am J Psychiatry. 2014 Jun;171(6):683-90 - PubMed
  45. Addiction. 2006 Feb;101(2):192-203 - PubMed
  46. Am J Addict. 2014 May-Jun;23(3):205-10 - PubMed
  47. Behav Res Ther. 1973 Feb;11(1):91-104 - PubMed
  48. Exp Clin Psychopharmacol. 2015 Dec;23(6):486-93 - PubMed
  49. Addiction. 2017 May;112(5):875-883 - PubMed
  50. J Law Med Ethics. 2011 Fall;39(3):450-68 - PubMed
  51. JMIR Serious Games. 2014 Feb 07;2(1):e2 - PubMed
  52. J Appl Behav Anal. 2008 Winter;41(4):609-15 - PubMed
  53. Nicotine Tob Res. 2006 Dec;8 Suppl 1:S69-76 - PubMed
  54. Arch Gen Psychiatry. 1975 Jul;32(7):915-8 - PubMed
  55. Addiction. 2013 May;108(5):900-9 - PubMed
  56. Nicotine Tob Res. 2014 Jun;16(6):766-73 - PubMed
  57. Behav Res Ther. 1983;21(4):425-33 - PubMed
  58. Drug Alcohol Depend. 2009 Apr 1;101(1-2):92-100 - PubMed
  59. Nicotine Tob Res. 2017 Mar 1;19(3):290-298 - PubMed
  60. Prev Med. 2016 Nov;92:36-46 - PubMed
  61. Nicotine Tob Res. 2013 Nov;15(11):1934-8 - PubMed
  62. Alcohol Clin Exp Res. 2018 Dec;42(12):2423-2431 - PubMed
  63. J Pediatr Pharmacol Ther. 2010 Oct;15(4):249-63 - PubMed
  64. Am J Public Health. 2004 Oct;94(10):1695-703 - PubMed
  65. Exp Clin Psychopharmacol. 1998 May;6(2):157-61 - PubMed
  66. Tob Control. 2014 Sep;23(5):428-33 - PubMed
  67. Behav Anal. 2004 Fall;27(2):209-30 - PubMed
  68. N Engl J Med. 2015 May 28;372(22):2108-17 - PubMed
  69. J Health Commun. 2011;16 Suppl 1:77-89 - PubMed
  70. JMIR Serious Games. 2018 Jun 07;6(2):e11 - PubMed
  71. Addict Behav. 1987;12(2):181-4 - PubMed
  72. Exp Clin Psychopharmacol. 2000 May;8(2):176-84 - PubMed
  73. J Med Toxicol. 2016 Sep;12(3):255-62 - PubMed
  74. Exp Clin Psychopharmacol. 2013 Apr;21(2):144-54 - PubMed
  75. Subst Abuse Rehabil. 2018 Aug 13;9:43-57 - PubMed
  76. Drug Alcohol Depend. 2007 Jan 12;86(2-3):230-8 - PubMed
  77. Addiction. 2012 Aug;107(8):1404-17 - PubMed
  78. J Appl Behav Anal. 2008 Winter;41(4):597-601 - PubMed
  79. J Appl Behav Anal. 2017 Apr;50(2):189-205 - PubMed
  80. Transl Issues Psychol Sci. 2016 Jun;2(2):128-152 - PubMed
  81. Alcohol. 2019 Dec;81:83-92 - PubMed
  82. J Clin Psychiatry. 2015 Jul;76(7):959-64 - PubMed
  83. Behav Anal. 2014 Apr 29;37(1):25-40 - PubMed
  84. Am J Psychiatry. 2008 Feb;165(2):179-87 - PubMed
  85. Exp Clin Psychopharmacol. 2015 Jun;23(3):176-83 - PubMed
  86. Nicotine Tob Res. 2018 Nov 18;:null - PubMed
  87. Exp Clin Psychopharmacol. 2017 Oct;25(5):333-337 - PubMed

Publication Types

Grant support